Heart Rate Management in Stable Angina

With a prevalence of 20-40 per 100,000 in the adult population, the prognosis of patients with stable angina is variable and risk stratification facilitates the selection of treatment options. Edited by Kim Fox and Roberto Ferrari, both leading clinical cardiologists and principal investigators for many clinical trials, "Heart Rate Management in Stable Angina" focuses on pharmaceutical therapies, covering important topics such as: - the management of stable angina with ivabradine, a new metabolic agent - goals for optimal treatment of patients with stable angina - clinical benefits of exclusive heart rate reduction in stable angina. The only book on the market to deal specifically with stable angina, "Heart Rate Management in Stable Angina" is undoubtedly a highly useful guide for clinicians.